4//SEC Filing
Cavanagh Bethany J 4
Accession 0000950170-24-111737
CIK 0001745999other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:51 PM ET
Size
7.3 KB
Accession
0000950170-24-111737
Insider Transaction Report
Form 4
Cavanagh Bethany J
SVP, Finance and Treasurer
Transactions
- Award
Common Stock
2024-09-30+2,500→ 45,220 total - Sale
Common Stock
2024-10-01$23.48/sh−289$6,785→ 44,931 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.
- [F2]These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain RSUs granted to the Reporting Person under the Plan on September 30, 2021. These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.45 to $23.48, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0002033155
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:51 PM ET
- Size
- 7.3 KB